EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Alzheimers Diagnosis 1st Edition Charles E Ronson

Name: Alzheimers Diagnosis 1st Edition Charles E Ronson
SKU: BELL-51369030
Price: 31.00 USD
Availability: InStock
Rating: 4.4 (22 reviews)

SKU: BELL-51369030

$ 31.00 ~~$ 45.00~~ (-31%)

4.4

22 reviews

Alzheimers Diagnosis 1st Edition Charles E Ronson instant download after payment.

Publisher: Nova Science Publishers, Incorporated

File Extension: PDF

File size: 7.3 MB

Pages: 278

Author: Charles E. Ronson

ISBN: 9781620816806, 1620816806

Language: English

Year: 2011

Edition: 1

Product desciption

Alzheimers Diagnosis 1st Edition Charles E Ronson by Charles E. Ronson 9781620816806, 1620816806 instant download after payment.

The demographics of aging suggest a great need for an early diagnosis of dementia and for the development of preventive strategies. Neurodegeneration in Alzheimer's disease is estimated to start 20-30 years before clinical onset, and the identification of biological markers for pre-clinical and early diagnosis is the principal aim of research studies in the field. In this book, the authors present topical research on Alzheimer's diagnosis including cerebrospinal fluid biomarker Amyloid-B 1-42 identification; visual impairment in Alzheimer's disease; cerebral glucose metabolism through F-fluoro-deoxy-glucose positron emission tomography and neuroimaging.